COHERUS BIOSCIENCES INC (CHRS) Stock Price, Quote, News and Overview

What is the stock price of COHERUS BIOSCIENCES INC today?

The current stock price of CHRS is 1.07 USD. The price decreased by -2.73% in the last trading session.

What is the ticker symbol for COHERUS BIOSCIENCES INC stock?

The exchange symbol of COHERUS BIOSCIENCES INC is CHRS and it is listed on the Nasdaq exchange.

On which exchange is CHRS stock listed?

CHRS stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for COHERUS BIOSCIENCES INC stock?

13 analysts have analysed CHRS and the average price target is 6.2 USD. This implies a price increase of 479.9% is expected in the next year compared to the current price of 1.07. Check the COHERUS BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is COHERUS BIOSCIENCES INC worth?

COHERUS BIOSCIENCES INC (CHRS) has a market capitalization of 123.27M USD. This makes CHRS a Micro Cap stock.

How many employees does COHERUS BIOSCIENCES INC have?

COHERUS BIOSCIENCES INC (CHRS) currently has 246 employees.

What are the support and resistance levels for COHERUS BIOSCIENCES INC (CHRS) stock?

COHERUS BIOSCIENCES INC (CHRS) has a resistance level at 1.11. Check the full technical report for a detailed analysis of CHRS support and resistance levels.

Is COHERUS BIOSCIENCES INC (CHRS) expected to grow?

The Revenue of COHERUS BIOSCIENCES INC (CHRS) is expected to decline by -1.89% in the next year. Check the estimates tab for more information on the CHRS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy COHERUS BIOSCIENCES INC (CHRS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CHRS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CHRS, evaluating the profitability, health, valuation and growth aspects
• COHERUS BIOSCIENCES INC (CHRS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• COHERUS BIOSCIENCES INC (CHRS) Sales and EPS estimates to see what analysts future expectations are.
• COHERUS BIOSCIENCES INC (CHRS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• COHERUS BIOSCIENCES INC (CHRS) Insider and Institutional Ownership to learn about the owners and their transactions.
• COHERUS BIOSCIENCES INC (CHRS) Stock Chart to make your own analysis
• COHERUS BIOSCIENCES INC (CHRS) Latest news and press-releases to stay up to date.

Does COHERUS BIOSCIENCES INC (CHRS) stock pay dividends?

CHRS does not pay a dividend.

When does COHERUS BIOSCIENCES INC (CHRS) report earnings?

COHERUS BIOSCIENCES INC (CHRS) will report earnings on 2025-02-27, after the market close.

What is the Price/Earnings (PE) ratio of COHERUS BIOSCIENCES INC (CHRS)?

COHERUS BIOSCIENCES INC (CHRS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.09).

What is the Short Interest ratio of COHERUS BIOSCIENCES INC (CHRS) stock?

The outstanding short interest for COHERUS BIOSCIENCES INC (CHRS) is 27.93% of its float. Check the ownership tab for more information on the CHRS short interest.

ChartMill assigns a fundamental rating of 2 / 10 to CHRS. CHRS may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months CHRS reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS increased by 45.5% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to CHRS. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 56.68% and a revenue growth -1.89% for CHRS